These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3839813)

  • 1. Evaluation of effectiveness of clofazimine therapy. I. Monitoring of absorption of clofazimine from gastrointestinal tract.
    Mathur A; Venkatesan K; Bharadwaj VP; Ramu G
    Indian J Lepr; 1985; 57(1):146-8. PubMed ID: 3839813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clofazimine: detailed studies of small intestine functions.
    Bhasin DK; Kumar B; Broor SL; Kaur S; Malik AM; Mehra SK
    Indian J Lepr; 1985; 57(2):364-72. PubMed ID: 4078364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of clofazimine in leprosy patients.
    Feng PC; Fenselau CC; Jacobson RR
    Drug Metab Dispos; 1981; 9(6):521-4. PubMed ID: 6120809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue levels of clofazimine in a case of leprosy.
    Desikan KV; Balakrishnan S
    Lepr Rev; 1976 Jun; 47(2):107-13. PubMed ID: 948215
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of one year clofazimine therapy on autonomic functions in lepromatous leprosy with lepra (ENL) reaction.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):278-85. PubMed ID: 6688841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B; Girdhar BK
    Indian J Lepr; 1986; 58(1):73-8. PubMed ID: 3746000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological aspects and the therapeutic effects of clofazimine.
    Irani SJ
    Lepr India; 1976 Oct; 48(4 Suppl):681-5. PubMed ID: 1026804
    [No Abstract]   [Full Text] [Related]  

  • 9. Clofazimine for leprosy and Mycobacterium avium complex infections.
    Med Lett Drugs Ther; 1987 Aug; 29(746):77-8. PubMed ID: 3614089
    [No Abstract]   [Full Text] [Related]  

  • 10. Clofazimine in lepra (ENL) reaction, one year clinical trial.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative estimation of clofazimine in tissue.
    Balakrishnan S; Desikan KV; Ramu G
    Lepr India; 1976 Oct; 48(4 Suppl):732-8. PubMed ID: 1026811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine.
    Freerksen E; Seydel JK
    Arzneimittelforschung; 1992 Oct; 42(10):1243-5. PubMed ID: 1472145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of toxicity of clofazimine with special reference to structural and functional status of small intestine.
    Kumar B; Bahadur B; Broor SL; Kaur S; Gangwar DN; Malik AK
    Lepr India; 1982 Apr; 54(2):246-55. PubMed ID: 7132294
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastro-intestinal side effects of clofazimine.
    Lal S; Garg BR; Hameedulla A
    Lepr India; 1981 Apr; 53(2):285-8. PubMed ID: 7253579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection.
    Garrelts JC
    DICP; 1991 May; 25(5):525-31. PubMed ID: 2068838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on drug interactions.
    Venkatesan K; Bharadwaj VP; Ramu G; Desikan KV
    Lepr India; 1980 Apr; 52(2):229-35. PubMed ID: 7453137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamprene (clofazimine) in leprosy. Basic information.
    Yawalkar SJ; Vischer W
    Lepr Rev; 1979 Jun; 50(2):135-44. PubMed ID: 396428
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.